Kidney Function Tests Global Market Report 2022: Sector to Reach $1.39 Billion by 2030 at a CAGR of 6.5%
February 27, 2023 08:38 ET
|
Research and Markets
Dublin, Feb. 27, 2023 (GLOBE NEWSWIRE) -- The "Kidney Function Tests Market Size, Share & Trends Analysis Report By Product (Clearance Tests, Urine Tests, Blood Tests, Dilution And Concentration...
Deepak Suri Named Chief Information Officer at Healthmap Solutions
December 21, 2021 09:05 ET
|
Healthmap Solutions
TAMPA, Fla., Dec. 21, 2021 (GLOBE NEWSWIRE) -- Healthmap Solutions, Inc. (Healthmap), an NCQA accredited kidney population health management company, announced the appointment of Deepak Suri as its...
Global Renal Care Management Market Research Report 2021: Value-based Renal Care to Provide a Strong Platform for Payer-driven Innovations and Major Industry Disruptions
September 29, 2021 07:13 ET
|
Research and Markets
Dublin, Sept. 29, 2021 (GLOBE NEWSWIRE) -- The "Global Renal Care Management Growth Opportunities" report has been added to ResearchAndMarkets.com's offering. The global prevalence of CKD is...
Mark Sprague Named Chief Financial Officer at Healthmap Solutions
September 21, 2021 09:05 ET
|
Healthmap Solutions
TAMPA, Fla., Sept. 21, 2021 (GLOBE NEWSWIRE) -- Healthmap Solutions, Inc. (Healthmap), an NCQA accredited kidney population health management company, today announced the appointment of Mark Sprague...
Howard Shaps, MD, MBA, Named Chief Clinical Officer at Healthmap Solutions
June 15, 2021 09:05 ET
|
Healthmap Solutions
TAMPA, Fla., June 15, 2021 (GLOBE NEWSWIRE) -- Healthmap Solutions, Inc. (Healthmap), an industry leading NCQA accredited kidney population health management company, today announced the appointment...
Diabetic Nephropathy Disease Analysis Report 2021: Overall Likelihood of Approval of a Phase I DN Asset is 4%, and the Average Probability a Drug Advances from Phase III is 33.3%
March 23, 2021 08:13 ET
|
Research and Markets
Dublin, March 23, 2021 (GLOBE NEWSWIRE) -- The "Disease Analysis: Diabetic Nephropathy" report has been added to ResearchAndMarkets.com's offering. Diabetic nephropathy, also known as diabetic...
Healthmap Solutions Urges Medicare Advantage Plans to Act Now In Advance of 21st Century Cures Act Implementation
July 22, 2020 09:00 ET
|
Healthmap Solutions
TAMPA, Fla., July 22, 2020 (GLOBE NEWSWIRE) -- Healthmap Solutions, a rapidly growing specialty Population Health Management (PHM) company with a flagship Kidney Health Management (KHM) program,...
Regence and Healthmap Solutions partner to provide Kidney Health Management program to members
June 11, 2020 09:00 ET
|
Healthmap Solutions
PORTLAND, Ore., June 11, 2020 (GLOBE NEWSWIRE) -- Regence today announced a new partnership with Healthmap Solutions—a growing national Population Health Management company with a flagship Kidney...
Proteon Therapeutics to Present at the JMP Securities Life Sciences Conference June 22nd
June 15, 2016 08:00 ET
|
Proteon Therapeutics, Inc.
WALTHAM, Mass., June 15, 2016 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of patients...
Rockwell Medical Enters Into Exclusive License Agreement With Wanbang Biopharmaceutical Co., Ltd. to Commercialize Triferic® in China
February 16, 2016 08:00 ET
|
Rockwell Medical, Inc.
WIXOM, Mich., Feb. 16, 2016 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ:RMTI), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney...